Comments: TN HB1216 | 2017-2018 | 110th General Assembly
Bill Title: As introduced, requires the commissioner of health, in consultation with the commissioner of mental health and substance abuse services, to study and report to the health committee of the house of representatives and the health and welfare committee of the senate, on or before January 15, 2018, concerning any recommended changes to prescribing guidelines for buprenorphine products, or to Tennessee Code Annotated, Section 53-11-311. - Amends TCA Title 53, Chapter 11, Part 3.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2017-02-15 - Assigned to s/c Health Subcommittee [HB1216 Detail]
Text: Latest bill text (Draft #1) [PDF]
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2017-02-15 - Assigned to s/c Health Subcommittee [HB1216 Detail]
Text: Latest bill text (Draft #1) [PDF]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2017 Tennessee HB1216 at this time. |